ESC 365 - Impact of CHA2DS2-VASc and HAS-BLED SCORES on oral anticoagulant use and outcomes in patients with atrial fibrillation and concomitant heart failure: an analysis of 22,055 patients from the SwedeHF

ESC Premium Access

Impact of CHA2DS2-VASc and HAS-BLED SCORES on oral anticoagulant use and outcomes in patients with atrial fibrillation and concomitant heart failure: an analysis of 22,055 patients from the SwedeHF

Session: Young Investigator Awards Session Population Sciences

Topic: Pharmacologic therapy

Speaker: Professor G. Savarese (Stockholm, SE)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Professor Gianluigi Savarese

Karolinska Institute, Stockholm (Sweden)

64 presentations

16 followers

3 more presentations in this session

Is dairy product intake related to risk of type 2 diabetes? A pan-European Mendelian Randomisation study.

Speaker: Doctor L. Vissers (Utrecht, NL)

Diagnostic and prognostic benefits of CTCA using the updated NICE guidance: An analysis of the Scottish computed tomography of the heart (SCOT-HEART) trial

Speaker: Doctor P. Adamson (Christchurch, NZ)

Cardiovascular risks associated with diclofenac initiation: a nationwide emulated randomized trial

Speaker: Doctor M. Schmidt (Aarhus, DK)

Access the full session

Young Investigator Awards Session Population Sciences

Speakers: Professor G. Savarese, Doctor L. Vissers, Doctor P. Adamson, Doctor M. Schmidt

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources